Skip to main content

J&J forecasts disappointing 2019 sales, defends talc safety

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts' estimates and said it expected further pressure on U.S. prescription drug prices, weighing on the broader pharmaceutical sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.